Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%
Harvey B Dubiner1, Robert Noecker21Clayton Eye Center, Morrow, GA; 2Ophthalmic Consultants of Connecticut, Fairfield, CT, USABackground: The purpose of this study was to characterize intraocular pressure (IOP) reduction throughout the day with travoprost ophthalmic solution 0.004% dosed once daily i...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/sustained-intraocular-pressure-reduction-throughout-the-day-with-travo-a9597 |